Reuters logo
BRIEF-Vbi vaccines provides update on its congenital CMV early-stage study
May 2, 2017 / 1:06 PM / 7 months ago

BRIEF-Vbi vaccines provides update on its congenital CMV early-stage study

May 2 (Reuters) - VBI Vaccines Inc-

* VBI Vaccines provides update on its congenital cmv phase i clinical study

* VBI Vaccines Inc - no safety signals have been detected, suggesting vbi’s cmv vaccine candidate is safe and well-tolerated

* VBI Vaccines Inc - an interim safety and immunogenicity report, is expected mid-year 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below